Active Pharmaceutical Ingredient

Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC

CAS: 83519-04-4 GMP Certified Aurangabad, Maharashtra, India
Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC — Mediocon Inc
Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC

Product Overview

CAS No: 83519-04-4

Limofosine (Ilmofosine) API is a synthetic alkyllysophospholipid derivative investigated primarily for its potential antineoplastic and antiproliferative activity. Ilmofosine is structurally related to other ether- and thioether-containing lysophospholipid analogues and has been studied as an experimental pharmaceutical compound in oncology research.

Ilmofosine is chemically described as 1-hexadecylthio-2-methoxyethyl-rac-glycero-3-phosphocholine. It has the molecular formula C₂₆H₅₆NO₅PS and molecular weight approximately 525.765 g/mol. The compound is reported as a racemic/mixed stereochemical material with no defined stereocenters in the primary NCATS substance record.

The compound has been investigated for potential antineoplastic activity, including research involving tumor cell lines and experimental cancer models. Its biological activity has been associated with effects on cellular signaling and membrane-associated processes, including reported inhibition of protein kinase C activity in experimental studies.

Ilmofosine has been studied experimentally in relation to several tumor types, including research involving leukemia and solid-tumor models. It should be regarded as an investigational compound rather than an established routine therapeutic API, and therapeutic or regulatory claims should therefore not be made without appropriate jurisdiction-specific evidence.

MEDIOCON INC supplies Limofosine (Ilmofosine) for applicable pharmaceutical research, analytical investigation, medicinal chemistry and formulation-development requirements, subject to product availability, applicable regulatory requirements and supporting documentation.

Key Applications

  • Anticancer research
  • Antineoplastic research
  • Alkyllysophospholipid research
  • Cell-signaling research
  • Protein kinase C research
  • Pharmaceutical R&D
  • Analytical research
  • Medicinal chemistry
  • Experimental formulation development

Product Specifications

Product NameLimofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC
CAS Number83519-04-4

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC (CAS 83519-04-4) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Limofosine (Ilmofosine) API Manufacturer & Supplier in India | MEDIOCON INC

What is Limofosine?
Limofosine is a reference/variant name associated with Ilmofosine, an investigational alkyllysophospholipid derivative studied for potential antineoplastic activity
💬
Mediocon AI
Hello 👋 How can I help you today?